GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wai Yuen Tong Medicine Holdings Ltd (HKSE:00897) » Definitions » PS Ratio

Wai Yuen Tong Medicine Holdings (HKSE:00897) PS Ratio : 0.19 (As of Jun. 08, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Wai Yuen Tong Medicine Holdings PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Wai Yuen Tong Medicine Holdings's share price is HK$0.216. Wai Yuen Tong Medicine Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was HK$1.14. Hence, Wai Yuen Tong Medicine Holdings's PS Ratio for today is 0.19.

The historical rank and industry rank for Wai Yuen Tong Medicine Holdings's PS Ratio or its related term are showing as below:

HKSE:00897' s PS Ratio Range Over the Past 10 Years
Min: 0.05   Med: 0.11   Max: 0.26
Current: 0.19

During the past 13 years, Wai Yuen Tong Medicine Holdings's highest PS Ratio was 0.26. The lowest was 0.05. And the median was 0.11.

HKSE:00897's PS Ratio is ranked better than
95.9% of 999 companies
in the Drug Manufacturers industry
Industry Median: 2.15 vs HKSE:00897: 0.19

Wai Yuen Tong Medicine Holdings's Revenue per Sharefor the six months ended in Sep. 2023 was HK$0.57. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was HK$1.14.

Warning Sign:

Wai Yuen Tong Medicine Holdings Ltd revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Wai Yuen Tong Medicine Holdings was 4.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 28.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 14.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was -17.20% per year.

During the past 13 years, Wai Yuen Tong Medicine Holdings's highest 3-Year average Revenue per Share Growth Rate was 46.90% per year. The lowest was -71.20% per year. And the median was -27.20% per year.

Back to Basics: PS Ratio


Wai Yuen Tong Medicine Holdings PS Ratio Historical Data

The historical data trend for Wai Yuen Tong Medicine Holdings's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wai Yuen Tong Medicine Holdings PS Ratio Chart

Wai Yuen Tong Medicine Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.14 0.09 0.06 0.09

Wai Yuen Tong Medicine Holdings Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.06 - 0.09 -

Competitive Comparison of Wai Yuen Tong Medicine Holdings's PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Wai Yuen Tong Medicine Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wai Yuen Tong Medicine Holdings's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wai Yuen Tong Medicine Holdings's PS Ratio distribution charts can be found below:

* The bar in red indicates where Wai Yuen Tong Medicine Holdings's PS Ratio falls into.



Wai Yuen Tong Medicine Holdings PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Wai Yuen Tong Medicine Holdings's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.216/1.135
=0.19

Wai Yuen Tong Medicine Holdings's Share Price of today is HK$0.216.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Wai Yuen Tong Medicine Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was HK$1.14.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Wai Yuen Tong Medicine Holdings  (HKSE:00897) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Wai Yuen Tong Medicine Holdings PS Ratio Related Terms

Thank you for viewing the detailed overview of Wai Yuen Tong Medicine Holdings's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Wai Yuen Tong Medicine Holdings (HKSE:00897) Business Description

Traded in Other Exchanges
N/A
Address
39 Wang Kwong Road, Suite 3101, 31st Floor, Skyline Tower, Kowloon Bay, Kowloon, Hong Kong, HKG
Wai Yuen Tong Medicine Holdings Ltd is an investment holding company. The company's operating segment includes production and sale of Chinese pharmaceutical and health food products; production and sale of Western pharmaceutical and health food products and property investment and management and sale of properties in the agricultural produce market. It generates maximum revenue from the production and sale of Chinese pharmaceutical and health food products which include manufacturing, processing, and sale of traditional Chinese medicine which includes Chinese medicinal products sold under the brand name Wai Yuen Tong. Geographically, it derives a majority of revenue from Mainland China.
Executives
Wang On Group Limited 2501 Other
Tang Ching Ho 2501 Other
Yau Yuk Yin 2202 Interest of your spouse

Wai Yuen Tong Medicine Holdings (HKSE:00897) Headlines

No Headlines